Xenetic Biosciences, Inc.

Pharmaceutical Preparations

NASDAQ.XBIO

945 Concord St., Framingham, MA, 01701

Latest Filings – Non-Ownership

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits

07 Nov 24

EFFECT

Notice Of Effectiveness For A Previously Filed Sec Document.

01 Nov 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers

31 Oct 24

DEFA14A

Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.

31 Oct 24

ARS

Scanned Paper Annual Report Submission.

31 Oct 24

DEF 14A

Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.

31 Oct 24

S-3

Registration Statement Under The Securities Act.

21 Oct 24

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Notification Filed By National Securities Exchanges Of The Removal From Listing And Registration Of Matured, Redeemed Or Retired Securities.

18 Jul 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers

21 Jun 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits

22 May 24

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Regulation Fd Disclosure

12 Feb 24

Latest Filings – Non-Ownership

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits

07 Nov 24

EFFECT

Notice Of Effectiveness For A Previously Filed Sec Document.

01 Nov 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers

31 Oct 24

DEFA14A

Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.

31 Oct 24

ARS

Scanned Paper Annual Report Submission.

31 Oct 24

DEF 14A

Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.

31 Oct 24

S-3

Registration Statement Under The Securities Act.

21 Oct 24

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Notification Filed By National Securities Exchanges Of The Removal From Listing And Registration Of Matured, Redeemed Or Retired Securities.

18 Jul 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers

21 Jun 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits

22 May 24

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Regulation Fd Disclosure

12 Feb 24

Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc.

Latest Filings – Non-Ownership

Latest Filings – Ownership

Latest Filings – Non-Ownership

Latest Filings – Ownership